These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 39091835)

  • 1. An enhancer-AAV toolbox to target and manipulate distinct interneuron subtypes.
    Furlanis E; Dai M; Leyva Garcia B; Vergara J; Pereira A; Pelkey K; Tran T; Gorissen BL; Vlachos A; Hairston A; Huang S; Dwivedi D; Du S; Wills S; McMahon J; Lee AT; Chang EF; Razzaq T; Qazi A; Vargish G; Yuan X; Caccavano A; Hunt S; Chittajallu R; McLean N; Hewit L; Paranzino E; Rice H; Cummins AC; Plotnikova A; Mohanty A; Tangen AC; Shin JH; Azadi R; Eldridge MAG; Alvarez VA; Averbeck BB; Alyahyay M; Reyes Vallejo T; Soheib M; Vattino LG; MacGregor CP; Banks E; Olah VJ; Naskar S; Hill S; Liebergall S; Badiani R; Hyde L; Xu Q; Allaway KC; Goldberg EM; Nowakowski TJ; Lee S; Takesian AE; Ibrahim LA; Iqbal A; McBain CJ; Dimidschstein J; Fishell G; Wang Y
    bioRxiv; 2024 Sep; ():. PubMed ID: 39091835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved neuronal transgene expression from an AAV-2 vector with a hybrid CMV enhancer/PDGF-beta promoter.
    Wang CY; Guo HY; Lim TM; Ng YK; Neo HP; Hwang PY; Yee WC; Wang S
    J Gene Med; 2005 Jul; 7(7):945-55. PubMed ID: 15756650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Silencer-delimited transgenesis: NRSE/RE1 sequences promote neural-specific transgene expression in a NRSF/REST-dependent manner.
    Xie X; Mathias JR; Smith MA; Walker SL; Teng Y; Distel M; Köster RW; Sirotkin HI; Saxena MT; Mumm JS
    BMC Biol; 2012 Nov; 10():93. PubMed ID: 23198762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Marked Diversity of Unique Cortical Enhancers Enables Neuron-Specific Tools by Enhancer-Driven Gene Expression.
    Blankvoort S; Witter MP; Noonan J; Cotney J; Kentros C
    Curr Biol; 2018 Jul; 28(13):2103-2114.e5. PubMed ID: 30008330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancer-Driven Gene Expression (EDGE) enables the generation of cell type specific tools for the analysis of neural circuits.
    Blankvoort S; Descamps LAL; Kentros C
    Neurosci Res; 2020 Mar; 152():78-86. PubMed ID: 31958494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. tTARGIT AAVs mediate the sensitive and flexible manipulation of intersectional neuronal populations in mice.
    Sabatini PV; Wang J; Rupp AC; Affinati AH; Flak JN; Li C; Olson DP; Myers MG
    Elife; 2021 Mar; 10():. PubMed ID: 33704065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional enhancer elements drive subclass-selective expression from mouse to primate neocortex.
    Mich JK; Graybuck LT; Hess EE; Mahoney JT; Kojima Y; Ding Y; Somasundaram S; Miller JA; Kalmbach BE; Radaelli C; Gore BB; Weed N; Omstead V; Bishaw Y; Shapovalova NV; Martinez RA; Fong O; Yao S; Mortrud M; Chong P; Loftus L; Bertagnolli D; Goldy J; Casper T; Dee N; Opitz-Araya X; Cetin A; Smith KA; Gwinn RP; Cobbs C; Ko AL; Ojemann JG; Keene CD; Silbergeld DL; Sunkin SM; Gradinaru V; Horwitz GD; Zeng H; Tasic B; Lein ES; Ting JT; Levi BP
    Cell Rep; 2021 Mar; 34(13):108754. PubMed ID: 33789096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deciphering transcription factors and their corresponding regulatory elements during inhibitory interneuron differentiation using deep neural networks.
    Alatawneh R; Salomon Y; Eshel R; Orenstein Y; Birnbaum RY
    Front Cell Dev Biol; 2023; 11():1034604. PubMed ID: 36891511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancer-Driven Gene Expression (EDGE) Enables the Generation of Viral Vectors Specific to Neuronal Subtypes.
    Nair RR; Blankvoort S; Lagartos MJ; Kentros C
    iScience; 2020 Mar; 23(3):100888. PubMed ID: 32087575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulatory Elements Inserted into AAVs Confer Preferential Activity in Cortical Interneurons.
    Rubin AN; Malik R; Cho KKA; Lim KJ; Lindtner S; Robinson Schwartz SE; Vogt D; Sohal VS; Rubenstein JLR
    eNeuro; 2020; 7(6):. PubMed ID: 33199411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimization of Recombinant Adeno-Associated Virus-Mediated Expression for Large Transgenes, Using a Synthetic Promoter and Tandem Array Enhancers.
    Yan Z; Sun X; Feng Z; Li G; Fisher JT; Stewart ZA; Engelhardt JF
    Hum Gene Ther; 2015 Jun; 26(6):334-46. PubMed ID: 25763813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimization of AAV vectors for transactivator-regulated enhanced gene expression within targeted neuronal populations.
    Kojima L; Seiriki K; Rokujo H; Nakazawa T; Kasai A; Hashimoto H
    iScience; 2024 Jun; 27(6):109878. PubMed ID: 38799556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome-Scale Analysis of Cellular Restriction Factors That Inhibit Transgene Expression from Adeno-Associated Virus Vectors.
    Ngo AM; Puschnik AS
    J Virol; 2023 Apr; 97(4):e0194822. PubMed ID: 36971544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel Striatal GABAergic Interneuron Populations Labeled in the 5HT3a(EGFP) Mouse.
    Muñoz-Manchado AB; Foldi C; Szydlowski S; Sjulson L; Farries M; Wilson C; Silberberg G; Hjerling-Leffler J
    Cereb Cortex; 2016 Jan; 26(1):96-105. PubMed ID: 25146369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of sequence determinants of enhancer function using natural genetic variation.
    Yang MG; Ling E; Cowley CJ; Greenberg ME; Vierbuchen T
    Elife; 2022 Aug; 11():. PubMed ID: 36043696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancer AAVs for targeting spinal motor neurons and descending motor pathways in rodents and macaque.
    Kussick E; Johansen N; Taskin N; Wynalda B; Martinez R; Groce EL; Reding M; Liang E; Shulga L; Huang C; Casper T; Clark M; Ho W; Gao Y; van Velthoven CTJ; Sobieski C; Ferrer R; Berg MR; Curtis BC; English C; Day JC; Fortuna M; Donadio N; Newman D; Yao S; Chakka AB; Goldy J; Torkelson A; Guzman JB; Chakrabarty R; Nguy B; Guilford N; Pham TH; Wright V; Ronellenfitch K; Gudsnuk K; Thyagarajan B; Smith KA; Dee N; Zeng H; Yao Z; Tasic B; Levi BP; Hodge R; Bakken TE; Lein ES; Ting JT; Daigle TL
    bioRxiv; 2024 Jul; ():. PubMed ID: 39131318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production of recombinant AAV vectors encoding insulin-like growth factor I is enhanced by interaction among AAV rep regulatory sequences.
    Shi S; Mercer SA; Dilley R; Trippel SB
    Virol J; 2009 Jan; 6():3. PubMed ID: 19128486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GABAergic neuron-specific whole-brain transduction by AAV-PHP.B incorporated with a new GAD65 promoter.
    Hoshino C; Konno A; Hosoi N; Kaneko R; Mukai R; Nakai J; Hirai H
    Mol Brain; 2021 Feb; 14(1):33. PubMed ID: 33588899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spinal nociceptive circuit analysis with recombinant adeno-associated viruses: the impact of serotypes and promoters.
    Haenraets K; Foster E; Johannssen H; Kandra V; Frezel N; Steffen T; Jaramillo V; Paterna JC; Zeilhofer HU; Wildner H
    J Neurochem; 2017 Sep; 142(5):721-733. PubMed ID: 28700081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AAV-mediated interneuron-specific gene replacement for Dravet syndrome.
    Mich JK; Ryu J; Wei AD; Gore BB; Guo R; Bard AM; Martinez RA; Bishaw Y; Luber E; Oliveira Santos LM; Miranda N; Ramirez JM; Ting JT; Lein ES; Levi BP; Kalume FK
    bioRxiv; 2023 Dec; ():. PubMed ID: 38168178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.